RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 109 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,673 | -59.2% | 20,990 | 0.0% | 0.00% | – |
| Q3 2022 | $9,000 | -50.0% | 20,990 | 0.0% | 0.00% | – |
| Q2 2022 | $18,000 | -97.8% | 20,990 | -85.7% | 0.00% | – |
| Q1 2022 | $811,000 | -43.5% | 147,257 | -0.7% | 0.00% | – |
| Q4 2021 | $1,435,000 | -57.9% | 148,260 | -22.2% | 0.00% | -100.0% |
| Q3 2021 | $3,408,000 | -34.0% | 190,609 | -9.9% | 0.00% | 0.0% |
| Q2 2021 | $5,165,000 | +1.0% | 211,601 | +9.7% | 0.00% | 0.0% |
| Q1 2021 | $5,112,000 | +326.7% | 192,893 | +22.2% | 0.00% | – |
| Q4 2020 | $1,198,000 | +58.7% | 157,810 | +4.6% | 0.00% | – |
| Q3 2020 | $755,000 | -16.5% | 150,876 | -0.2% | 0.00% | – |
| Q2 2020 | $904,000 | +55.1% | 151,224 | +15.3% | 0.00% | – |
| Q1 2020 | $583,000 | -56.1% | 131,171 | -6.2% | 0.00% | – |
| Q4 2019 | $1,328,000 | +35.0% | 139,785 | +11.6% | 0.00% | – |
| Q3 2019 | $984,000 | -48.5% | 125,255 | +3.1% | 0.00% | -100.0% |
| Q2 2019 | $1,911,000 | +19.4% | 121,496 | +37.4% | 0.00% | – |
| Q1 2019 | $1,600,000 | +162.7% | 88,404 | +133.7% | 0.00% | – |
| Q4 2018 | $609,000 | -13.9% | 37,825 | +28.4% | 0.00% | – |
| Q3 2018 | $707,000 | – | 29,468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |